Treatability study using prompt gamma neutron activation analysis (PGNAA) technology, Phase I. Topical report [report]

T.V. Congedo, A.R. Dulloo, F.H. Ruddy
1995 unpublished
doi:10.2172/172096 fatcat:teegrcrpn5gqvd6w4tkaaasbra